The Dermatology Residency program of the Department of Dermatology at Wake Forest School of Medicine and Wake Forest Baptist Medical Center is one of the premier dermatology training programs in the country. The strength of the program is a testimony to the quality of our faculty and their commitment to graduate medical education, serving the tradition of excellence established by our founding chair, Dr. Joseph Jorizzo, over 30 years ago.
Residents at the School of Medicine and Medical Center receive top-notch educational experiences in general medical dermatology, along with specialized training in:
- Complex medical dermatology
- Cutaneous oncology
- Cosmetic dermatology
- Contact and occupational dermatology
- Pediatric dermatology
- Inpatient and consultative dermatology
- Procedural dermatology, including Mohs micrographic surgery
Residents are also exposed to the scientific underpinnings of dermatology through an innovative basic science curriculum. In addition, residents assume increasing responsibilities during the course of their training through clinical dermatology, research and the teaching of medical students. This dynamic program offers residents the singular opportunity to take part in its growth and evolution.
Why Train at Wake Forest?
We offer a superior level of training, in part by keeping the full-time faculty-to-resident ratio at nearly 1:1. Each resident receives considerable individual attention from each of the faculty. We are committed to providing the highest level of educational experiences as set forth by the American Board of Dermatology and the Accreditation Council for Graduate Medical Education (ACGME).
Information for the 2021-2022 application cycle
Please check this site regularly for updates to the application process as well as information on application guidelines and answers to common questions.
We will interview approximately 55 applicants to select a class of 4 residents. The Wake Forest Dermatology Residency Program evaluates each application individually, and every application is discussed in our admissions committee without any preselection criteria. We conduct an additional review by our Chair or Program Director of any underrepresented in Medicine (URiM) applicant.
Regretfully we are unable to consider applicants who have completed a prior residency program. For applicants with visas, we are only able to consider those with a J-1 visa.
Supplemental ERAS Application
This year, our residency program will participate in the new AAMC Supplemental ERAS application, including token preference signaling. Completion of this supplemental application is encouraged for applicants to our program.
We will be using the data in the supplemental application to further our holistic review of each applicant. The information will be combined with the data in MyERAS to better understand your experiences, and allow you to highlight what is meaningful to you in your pathway to dermatology. We encourage you to be honest in your responses, as this will allow both us and you determine whether our program aligns with your experiences, goals and learning style.
Preference signaling is an option for an applicant to indicate particular interest in our program. Please do not signal our program if you are a Wake Forest medical student, or have completed an in-person away rotation in dermatology at our institution as a signal will provide no additional benefit. We are using signals in our initial application review but will not use them for ranking. Not sending a signal is not punitive; we will not know whether an applicant has decided not to submit signals generally, or not to signal our program specifically. As a program, we have historically engaged a holistic review of each application by a member of our application review committee. However given the sheer number of applications, if you have a specific interest in our program, a signal will ensure an in-depth review of your application by program leadership and may help to differentiate your application from others with similar experiences, backgrounds or metrics.
All interviews will be virtual this year, conducted on Friday, January 7, and Saturday, January 29, 2022. We would value the opportunity to meet in person and give our applicants the opportunity to know our faculty and residents, and explore our program and city. However, given the fluid situation with COVID-19 and concerns regarding the financial burden and inequities of in-person interviews, we have made the decision to proceed with virtual interviews this year.
We will be participating in the dermatology coordinated interview invite release, and will plan to release our first round of interview invites November 29, 2021, at 10:00 am EST and open interview scheduling on December 1, 2021, at 10:00 am EST.
The overarching goals of our residency program are to:
- Provide residents with a comprehensive understanding of the pathophysiology of skin diseases for the practice of dermatology
- Produce competent dermatologists who are socially and ethically concerned physicians
- Meet and exceed the competencies as established by the ACGME
- Train physicians who will be well equipped to assume positions of leadership in both clinical and academic dermatology
This is accomplished through the development of clinical knowledge and the acquisition of judgment in medical and procedural dermatology. The methods for reaching this objective are supervised patient management, surgeries, lectures, teaching rounds, and the development of individualized programs of reading and self-education.